1Y Close · As of Aug 26, 2026
Bio Solution operates in the Pharmaceuticals sector.
Legal name: Bio Solution Co.,Ltd.
In fiscal year 2025, Bio Solution (086820) reported revenue of 15.2 billion KRW, up 17.9% from 12.9 billion KRW a year earlier.
Operating profit was -4.3 billion KRW and net income was 273 million KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 181.7 billion KRW, with a P/B of 5.68.
These figures can be verified in the DART filing (receipt no. 20260319001181).
Checks
2 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-08-05 | [기재정정]주요사항보고서(전환사채권발행결정) |